These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

804 related items for PubMed ID: 10549990

  • 1. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G, Balducci G, Capristo E, Attilia ML, Taggi F, Gasbarrini G, Ceccanti M.
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [Abstract] [Full Text] [Related]

  • 2. Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study.
    Elsing C, Stremmel W, Grenda U, Herrmann T.
    Am J Drug Alcohol Abuse; 2009 Oct; 35(3):189-92. PubMed ID: 19462303
    [Abstract] [Full Text] [Related]

  • 3. Comparison of intravenous ethanol versus diazepam for alcohol withdrawal prophylaxis in the trauma ICU: results of a randomized trial.
    Weinberg JA, Magnotti LJ, Fischer PE, Edwards NM, Schroeppel T, Fabian TC, Croce MA.
    J Trauma; 2008 Jan; 64(1):99-104. PubMed ID: 18188105
    [Abstract] [Full Text] [Related]

  • 4. Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.
    Nuss MA, Elnicki DM, Dunsworth TS, Makela EH.
    W V Med J; 2004 Jan; 100(1):21-5. PubMed ID: 15119493
    [Abstract] [Full Text] [Related]

  • 5. Multidimensionality of the Alcohol Withdrawal Symptom Checklist: a factor analysis of the Alcohol Withdrawal Symptom Checklist and CIWA-Ar.
    Pittman B, Gueorguieva R, Krupitsky E, Rudenko AA, Flannery BA, Krystal JH.
    Alcohol Clin Exp Res; 2007 Apr; 31(4):612-8. PubMed ID: 17374040
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C, Chabannes JP, Saviuc P.
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [Abstract] [Full Text] [Related]

  • 12. Benzodiazepines for alcohol withdrawal in the elderly and in patients with liver disease.
    Peppers MP.
    Pharmacotherapy; 1996 Sep; 16(1):49-57. PubMed ID: 8700792
    [Abstract] [Full Text] [Related]

  • 13. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P, Touchon J, Billardon M.
    Encephale; 1997 Oct; 23(4):290-9. PubMed ID: 9417395
    [Abstract] [Full Text] [Related]

  • 15. [The effect of nifedipine and chlordiazepoxide on alcohol withdrawal syndrome].
    Samochowiec J, Fabiańczyk K, Reszczyński R, Czopek I, Pełka-Wysiecka J, Horodnicki JM.
    Psychiatr Pol; 1996 Oct; 30(2):307-20. PubMed ID: 8650291
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acupuncture in the treatment of alcohol withdrawal symptoms: a randomized, placebo-controlled inpatient study.
    Karst M, Passie T, Friedrich S, Wiese B, Schneider U.
    Addict Biol; 2002 Oct; 7(4):415-9. PubMed ID: 14578018
    [Abstract] [Full Text] [Related]

  • 18. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.
    McGregor C, Machin A, White JM.
    Drug Alcohol Rev; 2003 Jun; 22(2):175-80. PubMed ID: 12850904
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE, Naranjo CA, Bremner KE, Peachey JE, Bologa M.
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.